Late gadolinium enhancement cardiovascular MR for the Detection of Pre-Existent L

晚期钆增强心血管 MR 用于检测预先存在的 L

• 批准号: 7773155
• 负责人: DANA C PETERS
• 金额: $ 21.71万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-02-03 至 2011-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7773155
• 关键词: Ablation; Address; Affect; American; Area; Arrhythmia; Atrial Fibrillation; Biopsy; Breathing; Cardiac; Cardiac Surgery procedures; Cardiac ablation; Cardiovascular system; Cicatrix; Clinical; Clinical Data; Collaborations; Contrast Media; Controlled Study; Data; Detection; Electrophysiology (science); Elements; Enzymes; Fatty acid glycerol esters; Fibrosis; Gadolinium; Gold; Heart; Heart Atrium; Heart Rate; Histology; Histopathology; Hypertension; Image; Image Enhancement; Injection of therapeutic agent; Left; Left atrial structure; Location; Magnetic Resonance; Magnetic Resonance Imaging; Maps; Measurement; Medical; Methods; Mitral Valve Insufficiency; Modification; Morphologic artifacts; Myocardial; Non-Invasive Cancer Detection; Operative Surgical Procedures; Outcome; Patients; Pharmaceutical Preparations; Pharmacotherapy; Phase; Physiologic pulse; Population; Procedures; Pulmonary veins; Radiofrequency Interstitial Ablation; Recurrence; Reproducibility; Resected; Resolution; Risk; Role; Scanning; Schedule; Sinus; Solutions; Specificity; Structure; Techniques; Test Result; Testing; Time; Time Study; auricular appendage; cardiovascular imaging; high standard; improved; innovation; minimally invasive; novel; patient population; public health relevance; success; voltage

DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is a common arrhythmia, affecting almost 1% of the US population. Left atrial (LA) fibrosis has been identified in patients with AF, using biopsies, post-mortem analysis, and electrophysiological testing. However, the role of fibrosis is not known-whether it is a precursor to AF, maintains AF, or is a result of AF. Cardiovascular magnetic resonance (CMR) is capable of identifying scar with unparalleled precision, using the late gadolinium enhancement (LGE) technique. However, the thin myocardial LA wall presents challenges to identifying scar, especially for patients not in sinus rhythm. This proposal aims to improve the LGE method for detecting pre-existent scar. Firstly, the spatial resolution of LGE CMR method will be increased using increased SNR from a 32-element phased array cardiac coil. Image edge- enhancement will be reduced in the LGE images, using novel pulse sequence modifications to maintain necessary fat-suppression. A time-study of scar enhancement after injection of contrast agent will discriminate between scar and image artifacts. Many AF patients are not in sinus-rhythm. We propose a method for reducing artifacts due to RR variability. Using this LGE CMR method, we will study control subjects and patients prior to undergoing treatment either by catheter ablation, minimally invasive surgery, or drug therapy. The scar detected prior to therapy will be correlated with clinical outcomes. It will also be correlated with other methods for detecting scar--electrical mapping of the left atrium in patients undergoing catheter ablation, and histological analysis in patients undergoing surgery. This proposal will establish LGE CMR as method for detecting pre- existent fibrosis in AF patients. PUBLIC HEALTH RELEVANCE: Atrial fibrillation (AF) is a common arrhythmia. Some patients with AF have scar in their left atium, resulting from AF, or possibly causing AF. Cardiovascular magnetic resonance (CMR) is capable of identifying scar with unparalleled precision. However, the left atrial wall is a thin myocardial structure, presenting challenges to identifying scar. Furthermore, AF patients often have arrhythmias, which reduce image quality. We propose improving the CMR method for detecting scar in AF patients. Using this CMR scar method, we will study patients prior to undergoing treatment either by catheter ablation, minimally invasive surgery procedures, or drug therapy. The scar detected prior to therapy will be correlated with the later success of the therapy. It will also be correlated with other methods for detecting scar--electrical mapping of the left atrium and histological analysis in patients undergoing surgery. This study will result in a non- invasive method for identifying left atrial scar by CMR.

描述（由申请人提供）：房颤（AF）是一种常见的心律失常，影响近1%的美国人口。通过活组织检查、尸检分析和电生理测试，已在房颤患者中发现左心房（LA）纤维化。然而，纤维化的作用尚不清楚-它是否是AF的前兆，维持AF，或AF的结果。心血管磁共振（CMR）能够识别疤痕与无与伦比的精度，使用后期钆增强（LGE）技术。然而，薄的心肌LA壁对识别瘢痕提出了挑战，特别是对于非窦性心律的患者。该提案旨在改进用于检测先前存在的瘢痕的LGE方法。首先，LGE CMR方法的空间分辨率将使用来自32元件相控阵心脏线圈的增加的SNR来增加。将使用新的脉冲序列修改来减少LGE图像中的图像边缘增强，以保持必要的脂肪抑制。注射造影剂后疤痕增强的时间研究将区分疤痕和图像伪影。许多房颤患者不是窦性心律。我们提出了一种方法，用于减少由于RR变异性的伪影。使用这种LGE CMR方法，我们将研究对照受试者和接受导管消融、微创手术或药物治疗前的患者。治疗前检测到的瘢痕将与临床结局相关。它也将与其他检测疤痕的方法相关--接受导管消融术患者的左心房电标测，以及接受手术患者的组织学分析。该提案将确立LGE CMR作为检测AF患者中既存纤维化的方法。 公共卫生相关性：房颤（AF）是一种常见的心律失常。部分房颤患者的左心房有疤痕，这是房颤引起的，也可能是房颤的原因。心血管磁共振（CMR）能够以无与伦比的精度识别疤痕。然而，左心房壁是一个薄的心肌结构，提出了识别疤痕的挑战。此外，AF患者通常患有心律失常，这降低了图像质量。我们建议改进CMR方法用于检测AF患者的瘢痕。使用这种CMR瘢痕方法，我们将在接受导管消融、微创手术或药物治疗之前对患者进行研究。治疗前检测到的疤痕将与治疗的后期成功相关。它也将与其他检测疤痕的方法相关-左心房的电标测和手术患者的组织学分析。本研究将为CMR无创性鉴别左房瘢痕提供一种新的方法.